The increased expression of MAT2A (methionine adenosyltransferase 2A gene) in various cancers, including liver cancer, CRC, and gastric cancer, is recognized as a therapeutic target due to its role in regulating cell growth (81–84). This evidence concerns the gene MAT2A and gastric cancer.